Supplementary
. Determination of dosage level of NG-YSA-siRNAEGFR nanogels required to block proliferation of ovarian cancer cells in vivo. Two concentrations (3 mg/kg body weight or 7 mg/kg body weight) of siRNA-EGFR loaded nanogels (NG-YSA-siRNAEGFR) were injected into the tail veins (IV) of tumor bearing mice 18 days after the IP implantation of Hey A8-F8 cells. 48 hours after treatment, mice were sacrificed and tumors removed for histological analysis. The results of immunofluorescence imaging of EGFR and Ki67 (a biomarker of proliferative growth) expression levels in treated mice and untreated controls demonstrate that while EGFR (green , Fig 5a) levels are significantly reduced after treatment with a minimum of 3 mg/kg body weight of nanogels (p>0.001) (c, e), a dosage of 7 mg/kg body weight is needed to knock out levels of Ki67 (p>0.005) (f). Nuclei were counterstained with Hoechst 33342 (blue). 
